Siavash Beikoghli Kalkhoran Selected Research

Therapeutics

1/2022	Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission.
11/2016	From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research".

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Siavash Beikoghli Kalkhoran Research Topics

Disease

2	COVID-19 10/2022 - 10/2022
2	Myocardial Infarction 01/2022 - 11/2016
2	Reperfusion Injury 01/2022 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2016 - 09/2015
1	Cytokine Release Syndrome 10/2022
1	Infarction (Infarctions) 01/2022
1	Heart Failure 01/2022
1	Cardiotoxicity 08/2020
1	Cardiomyopathies (Cardiomyopathy) 08/2020
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2020
1	Heart Diseases (Heart Disease) 02/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2015

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 08/2020 - 09/2015
1	CytokinesIBA 10/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Hydralazine (Apresoline)FDA LinkGeneric 01/2022
1	AntioxidantsIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2020
1	LipidsIBA 11/2016
1	IntegrinsIBA 11/2016
1	Mitochondrial Permeability Transition PoreIBA 01/2015

Therapy/Procedure

2	Critical Care (Surgical Intensive Care) 10/2022 - 10/2022
2	Therapeutics 01/2022 - 11/2016
1	Precision Medicine 11/2016